Agile Therapeutics Inc (AGRX) Return on Investment ROI from the second quarter of 2024 to second quarter of 2023 and for the year 2024, average high and low, overall ranking from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Agile Therapeutics Inc  (AGRX)


Agile Therapeutics Inc's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Agile Therapeutics Inc's ROI in the second quarter of 2024?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Agile Therapeutics Inc's return on investment (ROI) in its second quarter of 2024

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -11 -9 -11 -7 -3
Return On Investment (TTM) - - - - -
AGRX's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - 164.82 % 77.48 %
Net Income (TTM) in Millions -16 -8 -14 8 3

AGRX Company Profile >> Back to AGRX Roi Comparisons >> See Annual AGRX Return On Investment



Return On Investment AGRX's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Agile Therapeutics Inc's II. Quarter Investments $ -11 Millions AGRX's Balance sheet
Agile Therapeutics Inc's II. Quarter Income $ -12 Millions Quarterly AGRX's Income Statement
AGRX's Income by Division See AGRX's Income by Division


AGRX Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions -11 1 10 66 46
Y / Y Investment Growth - -91.5 % -84.7 % 43.64 % 126.75 %
Net Income in Millions -14 -25 -75 -52 -19
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -2972.16 % -744.84 % -78.91 % -40.67 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AGRX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AGRX's Competitors
Subscribers only: Roi for Agile Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for AGRX's Customers

Other Ratios
AGRX's Roa AGRX's Inventory Turnover Ratio AGRX's Growth Rates AGRX's Dividend Statistics
AGRX's Profitability Ratios AGRX's Asset Turnover Ratio AGRX's Dividend Growth
AGRX's Roe AGRX's Valuation Ratios AGRX's Financial Strength Ratios AGRX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector ROI
Inhibrx Biosciences Inc   454.71 %
Ir med Inc   433.31 %
Kaya Holdings Inc   415.17 %
Interpace Biosciences Inc   243.24 %
WEED, INC.  238.52 %
Alaunos Therapeutics Inc   152.92 %
Camp4 Therapeutics Corporation  84.34 %
Roivant Sciences Ltd   77.20 %
Earth Science Tech Inc   73.25 %
Mimedx Group Inc   57.35 %
Guardion Health Sciences Inc   55.97 %
Biomx Inc  52.39 %
Entrada Therapeutics Inc   50.42 %
Siga Technologies Inc  50.32 %
Dariohealth Corp   50.05 %
Entera Bio Ltd   48.24 %
Scienture Holdings Inc   43.00 %
Protagonist Therapeutics inc   37.74 %
Mettler toledo International Inc   36.92 %
Medpace Holdings Inc   36.84 %
Valion Bio Inc   36.78 %
Nrc Health  36.51 %
Idexx Laboratories Inc  36.50 %
Pharmacyte Biotech Inc   36.30 %

Date modified: 2026-09-26T07:14:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.